# Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft Function

> **NCT07645599** · — · NOT_YET_RECRUITING · sponsor: **Roderick Tan** · enrollment: 40 (estimated)

## Conditions studied

- End Stage Chronic Renal Failure
- Renal Transplant
- Microvascular Changes
- Microvascular Circulation

## Interventions

- **DIAGNOSTIC_TEST:** Ultrasound contrast agent (Contrast-enhanced ultrasound)
- **DRUG:** Optison (Perflutren Protein-Type A Microspheres Injectable Suspension)
- **DRUG:** Lumason® contrast agent
- **DRUG:** DEFINITY®

## Key facts

- **NCT ID:** NCT07645599
- **Lead sponsor:** Roderick Tan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07645599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07645599, "Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft Function". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07645599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*